- Home
- SPGI vs PFE Comparison
SPGI vs PFE Comparison
Compare SPGI & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPGI | PFE |
|---|---|---|
| Founded | 1860 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.5B | 145.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SPGI | PFE |
|---|---|---|
| Price | $497.85 | $26.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 10 |
| Target Price | ★ $609.31 | $28.30 |
| AVG Volume (30 Days) | 1.5M | ★ 72.3M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | 0.77% | ★ 6.61% |
| EPS Growth | 21.42 | ★ 131.89 |
| EPS | ★ 13.74 | 1.73 |
| Revenue | $15,012,000,000.00 | ★ $62,785,000,000.00 |
| Revenue This Year | $9.85 | N/A |
| Revenue Next Year | $7.21 | N/A |
| P/E Ratio | $36.28 | ★ $15.13 |
| Revenue Growth | ★ 9.04 | 3.89 |
| 52 Week Low | $427.14 | $20.92 |
| 52 Week High | $579.05 | $27.69 |
Technical Indicators
Market Signals| Indicator | SPGI | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 53.01 | 60.05 |
| Support Level | $490.81 | $25.04 |
| Resistance Level | $502.10 | $25.89 |
| Average True Range (ATR) | 6.77 | 0.54 |
| MACD | 0.55 | 0.06 |
| Stochastic Oscillator | 73.15 | 94.84 |
Price Performance
Historical ComparisonAbout SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.